Scancell Holdings (SCLP) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Oct 2020 10:10 AM
RNS
Conversion of Convertible Loan Notes
21 Oct 2020 04:12 PM
RNS
Notice of Annual General Meeting
16 Oct 2020 07:00 AM
RNS
Final Results for the year ended 30 April 2020
15 Oct 2020 11:10 AM
RNS
Holding(s) in Company
14 Oct 2020 11:36 AM
RNS
Holding(s) in Company
13 Oct 2020 12:07 PM
RNS
Posting of Circular
12 Oct 2020 07:00 AM
RNS
Proposed investment by Redmile and Open Offer
05 Oct 2020 07:00 AM
RNS
Notice of Final Results
02 Oct 2020 07:00 AM
RNS
Collaboration to manufacture COVID-19 vaccine
24 Sep 2020 07:00 AM
RNS
Directorate Change
14 Sep 2020 04:41 PM
RNS
Second Price Monitoring Extn
14 Sep 2020 04:36 PM
RNS
Price Monitoring Extension
14 Sep 2020 09:05 AM
RNS
Second Price Monitoring Extn
14 Sep 2020 09:00 AM
RNS
Price Monitoring Extension
11 Sep 2020 04:41 PM
RNS
Second Price Monitoring Extn
11 Sep 2020 04:35 PM
RNS
Price Monitoring Extension
08 Sep 2020 04:40 PM
RNS
Second Price Monitoring Extn
08 Sep 2020 04:35 PM
RNS
Price Monitoring Extension
04 Sep 2020 07:00 AM
RNS
Director Award of Share Options
27 Aug 2020 07:00 AM
RNS
Funds awarded by Innovate UK for COVID-19 vaccine
26 Aug 2020 04:02 PM
RNS
Holding(s) in Company
25 Aug 2020 10:11 AM
RNS
Holding(s) in Company
12 Aug 2020 03:13 PM
RNS
Holding(s) in Company
12 Aug 2020 12:57 PM
RNS
Director Dealing
11 Aug 2020 10:54 AM
RNS
Results of General Meeting
23 Jul 2020 04:44 PM
RNS
Shareholder circular
22 Jul 2020 01:51 PM
RNS
Result of Placing and Notice of General Meeting
22 Jul 2020 07:00 AM
RNS
Proposed Capital Raise
24 Jun 2020 07:00 AM
RNS
New publication highlights potential of Modi-1
12 Jun 2020 09:30 AM
RNS
Publication highlights potential of AvidiMab
01 May 2020 07:00 AM
RNS
Director salaries and award of share options
29 Apr 2020 02:06 PM
RNS
Second Price Monitoring Extn
29 Apr 2020 02:00 PM
RNS
Price Monitoring Extension
28 Apr 2020 10:06 AM
RNS
Director Dealing
27 Apr 2020 04:39 PM
RNS
Director Dealing
24 Apr 2020 02:05 PM
RNS
Second Price Monitoring Extn
24 Apr 2020 02:00 PM
RNS
Price Monitoring Extension
24 Apr 2020 07:00 AM
RNS
Scancell: Development of vaccine against COVID-19
16 Mar 2020 04:42 PM
RNS
Second Price Monitoring Extn
16 Mar 2020 04:38 PM
RNS
Price Monitoring Extension
03 Mar 2020 07:00 AM
RNS
Scancell to Present at Three Research Conferences
03 Feb 2020 07:00 AM
RNS
SCIB1 IND Application Approved
31 Jan 2020 07:00 AM
RNS
Interim Results
20 Jan 2020 07:00 AM
RNS
Third agreement signed for antibody platform
17 Dec 2019 12:44 PM
RNS
Director's Dealings
16 Dec 2019 07:00 AM
RNS
Second agreement signed for AvidiMab platform
20 Nov 2019 07:00 AM
RNS
New European Moditope patent allowed for grant
23 Oct 2019 07:00 AM
RNS
Directorate Change
26 Sep 2019 07:00 AM
RNS
Posters at Cancer Immunotherapy Conference
12 Sep 2019 03:56 PM
RNS
Result of AGM

Scancell Holdings PLC is a biopharmaceutical company that develops vaccines and other therapies to treat cancer and infectious diseases. Scancell's research focuses on the human immune system and how to use it to develop new treatments. Scancell uses four technology platforms to develop its products: ImmunoBody, Moditope, GlyMab and AvidiMab.

Scancell was founded in 1997 based on research led by Professor Lindy Durrant at the University of Nottingham.

Scancell Holdings PLC is listed on the London Stock Exchange (LSE) as SCLP.

Scancell share price listed at 8p in 2010.

UK 100

Latest directors dealings